retatrutide triple agonist weight loss Severe Obesity Trial Shows 30% Retatrutide, a triple agonist, delivered

Family structure and unmet care needs among older adults with and without dementia in the United States

Trinerve-LC (L-carnitine + Methyl cobalamin + Folic Acid)

The findings provide a powerful counterpoint to the challenge of low medication adherence in real-world settings, where many patients stop taking GLP-1s before they can see the full clinical benefit

Therefore, when you eat less due to these medications, he noted, you may consume less protein as a result

PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes variants in FTO, MC4R, GLP1R, GIPR, and 46 other peptides across 14 pathways to reveal your genetic predisposition to weight regain